MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-KR-03-0068184
Medgenome Labs Limited - healthcare in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹406.98 Cr
▲ 36% YoY
Net profit · FY 2025
₹46.77 Cr
Net margin 11.5%
EBITDA · FY 2025
₹81.03 Cr
EBITDA margin 19.9%
Authorised capital
₹7 Cr
Registered with MCA
Paid-up capital
₹5.91 Cr
Issued & subscribed
Open charges
₹3.3 Cr
Satisfied ₹55.27 Cr
Company age
13 yrs
Est. 2013
Employees · EPFO
883
Provident fund records
About Medgenome Labs Limited
Data last updated:
Medgenome Labs Limited is a public limited company based in Bangalore, Karnataka, India, a subsidiary of Medgenome Inc.. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 08 April 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2013PLC084414. Its GSTIN is 29AAICM5351P1ZR (Karnataka). The company holds 11 GST registrations, of which 8 are active.
The company has an authorised share capital of ₹7 Cr and a paid-up capital of ₹5.91 Cr. It was formerly known as Medgenome Labs Private Limited. It is led by directors including Navjeewan Jatinder Khosla and Prasad Bhagwan Shejale.
Its last annual general meeting (AGM) was held on 27 November 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹406.98 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹46.77 Cr (net margin 11.5%) and EBITDA of ₹81.03 Cr (EBITDA margin 19.9%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 30% over five years.
The company has about 883 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
The company is associated with 2 brands: MedGenome and OneAssist. As per MCA filings, the company has open charges of ₹3.3 Cr and satisfied charges of ₹55.27 Cr on record. Court records list 4 cases involving the company, including 2 filed by the company and 2 filed against it; 2 cases are pending. The company has 15 deals on record (8 rights issues, 3 convertible or debt financings, 3 secondary share transfers), with disclosed funding of ₹85.55 Cr; the latest was in November 2025. The company has 12 MSME Form 1 returns on record between 2022 and 2024, listing 734 overdue payments to 38 micro and small suppliers.
Medgenome Labs Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0068184). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medgenome.com.
Company Details of Medgenome Labs Limited
CIN U73100KA2013PLC084414
Registration Number 084414
Incorporation Date 08 April 2013
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 November 2025
Date of Balance Sheet 31 March 2025
Parent Company Medgenome Inc.
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-KR-03-0068184
CIN History
Medgenome Labs has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U73100KA2013PLC084414, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100KA2013PLC084414 | Current |
| U73100KA2013PTC084414 | Previous |
| U73100TN2013PTC090471 | Previous |
Key People
Suryaprakasam Vedam Lakshmi Ramprasad Ceo Surajit Chakrabartty Cfo Navjeewan Jatinder Khosla Director Recognitions & Rankings of Medgenome Labs
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Apps
- Registered AddressSy. Nos. 94/1C And 94/2 Tower 1 Ground Floor, Veerasandra Village Attibele Hobli Electronic City Phase – 1, Bangalore, Karnataka, India – 560100
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
Comprehensive company report
Medgenome Labs Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands
Medgenome Labs operates two associated brands: MedGenome and OneAssist. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| DNA sequencing, bioinformatics, and multiomics services are provided. | medgenome.com | |
| Provider of protection plans and repair services for gadgets and appliances | oneassist.in |
Business Activity
The main business activities of Medgenome Labs are professional, scientific and technical and hospital and medical care. In detail, this covers scientific research and development and other hospital and medical care activities. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Medgenome Labs Limited
FY 2025 filings availableMedgenome Labs Limited reported revenue of ₹406.98 Cr (up 36% YoY) for FY 2025.
Revenue · FY 2025
₹406.98 Cr ▲ 36%
Net profit · FY 2025
₹46.77 Cr margin 11.5%
EBITDA · FY 2025
₹81.03 Cr margin 19.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 22%
5 years · compounded
▲ 30%
EBITDA CAGR growth
1 year
▲ 256%
3 years · compounded
▲ 20%
5 years · compounded
▲ 38%
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 36% growth in the latest year. EBITDA rose 256% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹81.03 Cr | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹46.77 Cr | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 19.9% | |
| Net Profit Margin | 11.5% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medgenome Labs are in the company report.
: available in the company report
Board of Directors and KMP of Medgenome Labs Limited
Medgenome Labs Limited currently reports 4 directors and 2 key managerial personnel. 7 former directors have served the organization.
Current Directors and KMP
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suryaprakasam Vedam Lakshmi Ramprasad Also directs: Green Cross Genetics Lab Private Limited, Genx Diagnostics Limited, Immucare Diagnostics Private Limited and 3 more | Ceo | 16 Nov 2023 | 2 Years 11 Months | Current |
| Surajit Chakrabartty Also directs: Ekavidha Corporate Services Private Limited, Green Cross Genetics Lab Private Limited, Genx Diagnostics Limited and 4 more | Cfo | 01 Dec 2014 | 11 Years 10 Months | Current |
| Navjeewan Jatinder Khosla | Director | 07 Nov 2024 | 1 Years 11 Months | Current |
| Prasad Bhagwan Shejale | Director | 30 Sep 2019 | 7 Years 0 Months | Current |
| Mahesh Pratapneni | Director | 30 Sep 2014 | 12 Years 0 Months | Current |
| Shankar Mahadevappa Prasad Also directs: Ekavidha Corporate Services Private Limited | Director | 24 Dec 2018 | 7 Years 9 Months | Current |
Auditor Details
Medgenome Labs Limited is audited by B S R & Associates LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B S R & Associates LLP | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Open charges
₹3.3 Cr
Satisfied charges
₹55.27 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Apr 2023 | Hdfc Bank Limited | ₹3.3 Cr | Open |
| 26 Jun 2019 | Others | ₹9.1 Cr | Satisfied |
| 15 Mar 2019 | Hdfc Bank Limited | ₹16.92 Cr | Satisfied |
| 02 Jun 2015 | Hdfc Bank Limited | ₹29.25 Cr | Satisfied |
Total charge records: 4 View all charges
Deals & Funding
Medgenome Labs Limited has 15 deals on record (8 rights issues, 3 convertible or debt financings, 3 secondary share transfers), with disclosed funding of ₹85.55 Cr; the latest was in November 2025.
Total deals
15
Rights issues
8
Convertible or debt financings
3
Secondary share transfers
3
Debt financing
1
Disclosed funding
₹85.55 Cr
Deals on record (5 of 15)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2025 | Rights issue | ₹498.09 Cr | Investors: Medgenome Inc |
| Jul 2024 | Rights issue | ₹82.17 Cr | Investors: Medgenome Inc |
| Sep 2014 | Secondary share transfer | Undisclosed | Buyer: Medgenome Inc Seller: Scigenom Labs Private Limited |
| Aug 2014 | Secondary share transfer | Undisclosed | Buyer: Medgenome Inc Seller: Scigenom Labs Private Limited |
| May 2014 | Secondary share transfer | Undisclosed | Buyer: Scigenom Labs Private Limited Seller: an individual |
: available in the company report
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases
Medgenome Labs Limited has 4 court cases on record: 2 filed by Medgenome Labs, 2 filed against it. 2 cases are pending and 2 are disposed.
Total cases
4
Filed by the company
2
Filed against the company
2
Pending
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 1 | 2 |
| High courts | 1 | 1 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Court case (Ex.COMM - Award by Arb. Comm.) | Filed by the company against Neotech World Lab Pvt Ltd. | Pending |
| District court, BENGALURU RURAL, Karnataka | Court case (Com.A.P.) | Filed against the company by Anu Hospitals Limited | Pending |
| High Court, KARNATAKA | Tax appeal | Filed against the company by Commissioner of Central Tax | Disposed |
| District court, BENGALURU RURAL, Karnataka | Criminal complaint | Filed by the company against individuals | Disposed |
: available in the company report
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays
Medgenome Labs Limited has 12 MSME Form 1 returns on record between 2022 and 2024, listing 734 overdue payments to 38 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 38)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Pathnsitu Biotechnologies Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Labsupplies India Private Limited | •••• | •••• | •••• |
| Shree Biomed | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
: available in the company report
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance
Medgenome Labs Limited has a workforce of 883 employees as of Apr 05, 2024.
Employee count
883
Active EPFO establishments
1
Employee growth
9.55%
: available in the company report
Group Structure
Medgenome Labs has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
2
Subsidiary companies
Key Subsidiaries
| Company Name | CIN | Shares Held |
|---|---|---|
| Immucare Diagnostics Private Limited | U85300KL2019PTC057597 | Locked |
| Trident Diagnostics & Healthcare Private Limited | U93090KA2016PTC094610 | Locked |
Showing major subsidiaries. Total: 2.
Recent Activity
Medgenome Labs Limited has 12 board changes on record since 2014: 6 appointments and 6 cessations. The latest: Balamaniamma Madathinkal Raghavan Nair ceased to be Director on 20 Feb 2025.
AGM
Medgenome Labs Limited last Annual general meeting of members was held on 27 Nov 2025 as per latest MCA records.
Filing
Medgenome Labs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Balamaniamma Madathinkal Raghavan Nair ceased to be Director.
Ceased
Navjeewan Jatinder Khosla ceased to be Additional Director.
Appointed
Navjeewan Jatinder Khosla was appointed as Director.
Charges
A charge registered on 15 Mar 2019 via Charge ID 100248275 with Hdfc Bank Limited was fully satisfied on 23 Sep 2024.
Ceased
Sreedhar Santhosh ceased to be Director.
Appointed
Suryaprakasam Vedam Lakshmi Ramprasad was appointed as CEO.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 3.30 Cr with Charge ID 100755877 was registered on 28 Apr 2023.
Ceased
Amit Kakar ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited of Rs. 16.92 Cr registered on 15 Mar 2019 with Charge ID 100248275 was modified on 18 Dec 2021.
Charges
A charge registered on 02 Jun 2015 via Charge ID 10583518 with Hdfc Bank Limited was fully satisfied on 18 Dec 2021.
12 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Medgenome Labs has 11 GST registrations: 8 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
11
Active
8
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAICM5351P1ZR | Karnataka | Active | 01 Jul 2017 |
| 29AAICM5351P2ZQ | Karnataka | Active | 01 May 2021 |
| 29AAICM5351P3ZP | Karnataka | Active | 25 Apr 2024 |
| 24AAICM5351P1Z1 | Gujarat | Active | 01 Jul 2017 |
: available in the company report
MCA Filings & Documents
: available in the company report
Related news
Frequently Asked Questions
Medgenome Labs is an active public limited company based in Bangalore, Karnataka, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 08 April 2013 (13+ years old) and is registered under CIN U73100KA2013PLC084414.
Medgenome Labs has 6 current directors and KMP:
- Navjeewan Jatinder Khosla - Director
- Prasad Bhagwan Shejale - Director
- Mahesh Pratapneni - Director
- Shankar Mahadevappa Prasad - Director
- Suryaprakasam Vedam Lakshmi Ramprasad - Ceo
- Surajit Chakrabartty - Cfo
The latest financial statements of Medgenome Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 November 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Medgenome Labs is 29AAICM5351P1ZR, registered in Karnataka. The company has 11 GST registrations in all, of which 8 are active and 3 are cancelled or inactive. Other active GSTINs include 29AAICM5351P2ZQ (Karnataka), 29AAICM5351P3ZP (Karnataka), 24AAICM5351P1Z1 (Gujarat).
The CIN (Corporate Identification Number) of Medgenome Labs is U73100KA2013PLC084414. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medgenome Labs has 4 court cases on record: 2 filed by the company and 2 filed against it. 2 are pending. Most are in the district courts.
Medgenome Labs was incorporated on 08 April 2013, making it 13+ years old. It is registered with the Registrar of Companies, Bangalore.
Medgenome Labs has 15 deals on record (8 rights issues, 3 convertible or debt financings, 3 secondary share transfers), with disclosed funding of ₹85.55 Cr; the latest was in November 2025.
Balamaniamma Madathinkal Raghavan Nair ceased to be Director on 20 Feb 2025. Navjeewan Jatinder Khosla ceased to be Additional Director on 25 Dec 2024. Navjeewan Jatinder Khosla was appointed as Director on 07 Nov 2024. Medgenome Labs has 12 board changes on record in total.
Yes, Medgenome Labs is registered as a medium enterprise under Udyam registration (number: UDYAM-KR-03-0068184).
Medgenome Labs has 12 MSME Form 1 returns on record between 2022 and 2024, listing 734 overdue payments to 38 micro and small suppliers. The latest return was filed on 30 Apr 2024.